HIV
News
HIV research update: Late July 2016
Treatment for HIV infection can be started on the day of diagnosis without impacting the safety or acceptability of antiretroviral therapy. Read...
News
New HIV antiretroviral guidelines embrace PrEP, early ART
The International Antiviral Society–USA has updated its recommendations for the use of antiretroviral drugs to treat or to prevent HIV infection...
Conference Coverage
Extended-release naltrexone helps alcohol-dependent HIV-positive prisoners transition to community
DURBAN, SOUTH AFRICA – Extended-release naltrexone helps HIV-infected prisoners with alcohol use disorder in transitioning to the community.
Conference Coverage
Psychiatric disorders often impair antiretroviral adherence in perinatally HIV-infected teens
DURBAN, SOUTH AFRICA – Look for and treat psychiatric disorders in perinatally HIV-infected adolescents to optimize their adherence to...
Conference Coverage
Who benefits most from immediate HIV therapy?
DURBAN, SOUTH AFRICA – Investigators have identified four specific subgroups of asymptomatic HIV-infected adults who obtain the most clinical...
News
Zoledronic acid protects against bone density loss caused by antiretrovirals
HIV patients undergoing antiretroviral therapy for the first time should be given 5 mg of zoledronic acid at the start to prevent bone density...
Conference Coverage
Gay and bisexual male high schoolers have high injected drug use
DURBAN, SOUTH AFRICA – Male U.S. students in grades 9-12 who identify themselves as sexual minorities have markedly higher rates of illicit drug...
News
HIV research update: Early July 2016
Short cycle antiretroviral therapy is a viable option for adherent HIV-infected young people who are stable on efavirenz-based ART. Read about...
News
Indiana HIV outbreak linked to injection use of oxymorphone
The 2014-2015 HIV infection outbreak in Indiana was associated with the injection-drug use of the extended-release opioid oxymorphone.
News
Global HIV/AIDS mortality declines, but infection rate is unimproved
HIV/AIDS mortality has been declining at a steady pace since 2005, but the annual rate of new infections has remained relatively constant in that...
Conference Coverage
Dapivirine vaginal ring sharply reduces HIV infection risk
DURBAN, SOUTH AFRICA – A novel device for preventing HIV infection in women achieved risk reductions of up to 75%-91%, compared with placebo.